What is the incidence of treatment-related intercurrent events common in clinical trials in patients with major depressive disorder?
Study objectives, to examine the proportion of patients with newly diagnosed major depressive disorder who start treatment with antidepressants, NSRIs, SSRIs, or other anti-depressants, as well as those who switch or discontinue treatment at specific intervals 4, 6, 8, 12, and 24 weeks after treatment initiation, stratified by age, sex, and country - database during the study period 2013 - 2022, to estimate the duration of antidepressant, use in patients with newly diagnosed major depressive disorder who initiate treatment with antidepressants, NSRIs, SSRIs, or other antidepressants, stratified by age, sex, and country - database during the study period 2013 - 2022, to assess the proportions of patients with newly diagnosed major depressive disorder who initiate, switch, or discontinue treatment with psycholeptics, antipsychotics, anxiolytics, hypnotics, and sedatives at specific intervals 4, 6, 8, 12, and 24 weeks after starting antidepressant therapy, stratified by age, sex, and country - database during the study period 2013 - 2022.